Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

10(90.9%)

Phase 3

1(9.1%)

11Total

N/A(10)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT07623811Not ApplicableNot Yet Recruiting

Efficacy and Safety of Acute Topical and Aromatic Essential Oil-Based Products for Cognitive Support

Role: lead

NCT07482644Not ApplicableNot Yet Recruiting

Efficacy and Safety of an Essential Oil-Based Product System for Immune Support

Role: lead

NCT07473544Not ApplicableActive Not Recruiting

Essential Oil Inhalation and Acute Stress Response in Healthy Adults

Role: lead

NCT06931977Not ApplicableCompleted

Natural Product System and Lifestyle Modification

Role: lead

NCT06492694Not ApplicableCompleted

Omega-3 Supplement and Health Markers

Role: lead

NCT06488417Not ApplicableCompleted

Frankincense Supplements and Inflammation

Role: lead

NCT06510335Not ApplicableCompleted

Lavender Essential Oil-based Product System for Sleep

Role: lead

NCT05832463Not ApplicableCompleted

Effects of a Novel Supplement on Glycemic Variability Measured by Continuous Glucose Monitoring

Role: lead

NCT04396444Not ApplicableCompleted

Lavender Aromasticks for Pain Control

Role: collaborator

NCT05021146Not ApplicableUnknown

Essential Oil for Chronic Low Back Pain

Role: collaborator

NCT03093454Phase 3Completed

Effects of Lavender Oil on Postoperative Pain, Sleep Quality and Mood

Role: collaborator

All 11 trials loaded